XENETIC BIOSCIENCES, INC. Investing Cash Flow
XENETIC BIOSCIENCES, INC. (XBIO) reported Investing Cash Flow of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-03-21
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2022-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$500.00K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2021 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Investing Activities 1 month | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 7 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 10 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 19 month | Net Cash Provided by (Used in) Investing Activities 22 month |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | ||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | ||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | -$500.00K 10-K · filed 2024-03-21 | ||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$500.00K 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | -$500.00K 10-Q · filed 2023-08-10 | ||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | ||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | ||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 | |||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $2.00K 10-K · filed 2021-03-16 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $2.00K 10-Q · filed 2020-11-12 | $2.00K derived: sum of 4 quarters · filed 2020-11-12 | |||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $2.00K 10-Q · filed 2020-08-12 | $2.00K derived: sum of 3 quarters · filed 2020-08-12 | $24.50K derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-14 | $2.00K derived: sum of 2 quarters · filed 2020-05-14 | $24.50K derived: sum of 3 quarters · filed 2020-05-14 | $24.50K derived: sum of 4 quarters · filed 2020-05-14 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $22.50K derived: sum of 2 quarters · filed 2020-03-26 | $22.50K derived: sum of 3 quarters · filed 2020-03-26 | $22.50K 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | $22.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $22.50K derived: sum of 2 quarters · filed 2019-11-14 | $22.50K 10-Q · filed 2019-11-14 | $22.50K derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-08-14 | $0.00 derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | $0.00 derived: sum of 2 quarters · filed 2019-05-13 | $0.00 derived: sum of 3 quarters · filed 2019-05-13 | -$3.83K derived: sum of 4 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | -$3.83K derived: sum of 3 quarters · filed 2019-03-29 | -$9.26K 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$3.83K derived: sum of 2 quarters · filed 2018-11-09 | -$9.26K 10-Q · filed 2018-11-09 | -$11.44K derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | -$3.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$9.26K 10-Q · filed 2018-08-10 | -$11.44K derived: sum of 3 quarters · filed 2018-08-10 | ||||||
| 2017-03-31 | -$5.43K 10-Q · filed 2018-05-15 | -$7.61K derived: sum of 2 quarters · filed 2018-05-15 | |||||||
| 2016-12-31 | -$2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$16.79K 10-K · filed 2018-03-30 | |||||||
| 2016-09-30 | -$14.61K 10-Q · filed 2017-11-14 | ||||||||
| 2013-12-31 | -$144.63K 10-K · filed 2015-07-20 | ||||||||
| 2013-08-31 | -$259.39K 10-K · filed 2013-11-27 | ||||||||
| 2013-05-31 | -$212.50K 10-Q · filed 2013-07-17 | ||||||||
| 2013-02-28 | -$212.50K 10-Q · filed 2013-04-22 | ||||||||
| 2012-12-31 | -$92.59K 10-K · filed 2015-07-20 | ||||||||
| 2012-05-31 | -$212.50K 10-Q · filed 2012-07-16 | ||||||||
| 2012-02-29 | -$212.50K 10-Q · filed 2012-04-24 | ||||||||
| 2011-08-31 | -$212.50K 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |